MICU2

MICU2 is an EF-hand Ca²⁺-sensing protein of the mitochondrial calcium uniporter (MCU) complex that gates mitochondrial Ca²⁺ uptake by tuning the threshold and cooperativity of MICU1-mediated channel inhibition and activation. MICU2 resides in the mitochondrial intermembrane space as a Mia40-dependent disulfide-bonded heterodimer with MICU1, and this heterodimer binds the MCU–EMRE pore at resting Ca²⁺ to block ion flow, then undergoes Ca²⁺-induced conformational changes that relieve inhibition above a cytosolic Ca²⁺ threshold (PMID:26387864, PMID:32667285, PMID:29241542). MICU2 requires MICU1 for its physical association with MCU but contributes a non-redundant gatekeeping function: its loss abolishes the Ca²⁺ uptake threshold and disrupts mitochondrial Ca²⁺ homeostasis in cardiomyocytes, pancreatic β cells, and developing cortical neurons (PMID:24503055, PMID:29073106, PMID:33932586, PMID:41273721). Loss-of-function mutation in human MICU2 causes a severe neurodevelopmental disorder linked to impaired mitochondrial Ca²⁺ handling and increased oxidative stress sensitivity (PMID:29053821).

1. 2013 High

   Establishing that MICU2 is a bona fide subunit of the MCU complex—not merely a paralog of MICU1—resolved whether the uniporter contains additional regulatory components beyond MCU and MICU1.

   Evidence Co-immunoprecipitation, biochemical fractionation, and in vivo RNAi in mouse liver with Ca²⁺ uptake assays

   PMID:23409044

   Open questions at the time

   • Whether MICU2 and MICU1 have distinct or overlapping gating functions was unresolved
   • Stoichiometry and direct contacts within the complex were unknown
   • Cell-type specificity of MICU2's contribution was not systematically explored
2. 2014 High

   Demonstrating that MICU2 knockout abolishes the Ca²⁺ threshold for MCU activation—and that its EF-hand mutants act as dominant negatives—established MICU2 as a non-redundant gatekeeper that requires MICU1 for association with the channel.

   Evidence CRISPR knockout in HEK-293T cells, EF-hand mutagenesis, Ca²⁺ uptake assays, co-immunoprecipitation

   PMID:24503055

   Open questions at the time

   • How MICU2 mechanistically modifies MICU1's gating activity was unclear
   • Whether MICU2 directly contacts MCU or only contacts MICU1 was unknown
3. 2015 High

   Identifying the Mia40-catalyzed intermolecular disulfide bond between MICU1 and MICU2 revealed how the heterodimer is assembled and how its Ca²⁺-dependent dissociation from MCU controls gating.

   Evidence Mia40 interactome analysis, disulfide bond mapping, co-immunoprecipitation, Ca²⁺ uptake assays with cysteine mutants

   PMID:26387864

   Open questions at the time

   • Role of non-covalent interactions in heterodimer stability was not fully delineated
   • Whether other oxidoreductases can substitute for Mia40 was untested
4. 2016 Medium

   Showing that MICU2 transitions from monomer to dimer in a Ca²⁺- and EF1-dependent manner, and that salt bridges also stabilize the MICU1–MICU2 interaction, provided biophysical detail on the Ca²⁺-sensing switch.

   Evidence Size exclusion chromatography with multi-angle light scattering, EF-hand mutagenesis, pull-down assays

   PMID:27534699

   Open questions at the time

   • Findings from a single lab; independent biophysical replication was lacking
   • Physiological relevance of MICU2 homodimerization versus heterodimer with MICU1 was unclear
5. 2017 High

   Electrophysiological dissection in KO cells established that MICU1 alone mediates both gatekeeping and cooperative activation, while MICU2 specifically tunes the Ca²⁺ threshold and gain, restricting Ca²⁺ crosstalk between single IP₃R and MCU channels.

   Evidence Patch-clamp electrophysiology of MCU across controlled Ca²⁺ concentrations in MICU1/2 KO cells

   PMID:29241542

   Open questions at the time

   • Structural basis for how MICU2 modifies MICU1's cooperative activation was unknown
   • Whether this tuning role operates identically in non-excitable versus excitable cells was untested
6. 2017 High

   In vivo knockout of Micu2 in mice revealed that MICU2 is essential for normal cardiac relaxation and angiotensin II signaling, linking uniporter gating to organ-level physiology; separately, a human loss-of-function MICU2 mutation was shown to cause a severe neurodevelopmental disorder with impaired mitochondrial Ca²⁺ handling.

   Evidence Micu2⁻/⁻ mouse model with cardiac phenotyping, RNA-seq, angiotensin II challenge; human exome sequencing with patient-derived cell functional assays

   PMID:29053821 PMID:29073106

   Open questions at the time

   • Human disease link based on a single family study; broader genetic confirmation was needed
   • Mechanism connecting MICU2 loss to reduced apelin receptor expression was not established
7. 2019 High

   The 2.5 Å crystal structure of MICU2 revealed a two-lobe architecture with two canonical and two structural EF-hands, and showed that the C-terminal helix is dispensable for MICU1 binding in vitro but required for cellular gating function, implicating it as an effector element.

   Evidence X-ray crystallography of apo mouse MICU2, EF-hand mutagenesis, in vitro binding and cellular Ca²⁺ assays

   PMID:30755530

   Open questions at the time

   • No Ca²⁺-bound MICU2 structure was available to visualize conformational switching
   • How the C-terminal helix contributes to gating at the channel interface was unknown
8. 2020 High

   Cryo-EM structures of the MCU–EMRE–MICU1–MICU2 holocomplex (3.3 Å) and Ca²⁺-bound MICU1–MICU2 heterodimer (3.1 Å) revealed the structural basis of gating: MICU1 contacts MCU/EMRE to block the pore, and Ca²⁺ binding triggers conformational rearrangement of the MICU1–MICU2 cap.

   Evidence Cryo-EM of the full holocomplex and Ca²⁺-bound MICU1–MICU2 dimer

   PMID:32667285

   Open questions at the time

   • Dynamics of gating transition between inhibited and activated states were not captured
   • Direct visualization of MICU2's C-terminal helix in the holocomplex context was limited
9. 2021 High

   MICU2 deficiency in pancreatic β cells abrogates glucose-stimulated insulin secretion by preventing mitochondrial Ca²⁺ uptake, membrane hyperpolarization, and ATP/ADP ratio increases, establishing MICU2 as critical for metabolic stimulus–secretion coupling.

   Evidence siRNA in INS-1 and EndoC-βH1 cells, Micu2⁻/⁻ mouse islets, live Ca²⁺ and membrane potential imaging, ATP/ADP measurements

   PMID:33932586

   Open questions at the time

   • Whether MICU2 loss alters β-cell function through Ca²⁺-independent pathways was not excluded
   • Long-term metabolic consequences in vivo were not assessed
10. 2024 High

    Demonstration that MICU1 and MICU2 together gate cardiac mitochondrial Ca²⁺ influx in human heart tissue, and that MICU1 deletion triggers compensatory remodeling of MCU complex composition, established the gating pair's relevance in human cardiac physiology.

    Evidence Co-immunoprecipitation in non-failing human hearts, murine MICU1/MICU2 KO models, mitochondrial Ca²⁺ imaging, energy metabolism assays

    PMID:39163336

    Open questions at the time

    • Whether compensatory remodeling also occurs upon isolated MICU2 loss in human heart was not tested
    • Relevance to heart failure pathophysiology was not directly addressed
11. 2025 High

    Showing that MICU2 is transiently expressed in developing but not mature mouse brain, and that its loss causes neuronal overmigration and augmented mitochondrial Ca²⁺ in cortical neurons—mirroring Ca²⁺ defects in patient fibroblasts—established MICU2 as a neurodevelopmentally restricted gatekeeper.

    Evidence Micu2 KO mice, live Ca²⁺ imaging in primary cortical neurons and patient fibroblasts, cortical migration assays, behavioral testing

    PMID:41273721

    Open questions at the time

    • What replaces MICU2's gating function in the mature brain is unknown
    • Whether MICU2's developmental expression pattern is conserved in humans was not confirmed

• The structural mechanism by which MICU2 specifically tunes MICU1's cooperative Ca²⁺ activation—and whether its C-terminal helix directly contacts the MCU pore during the gating transition—remains unresolved.
• No structure capturing the full gating transition in a membrane-embedded context exists
• Tissue-specific stoichiometric variation of MICU2 within the uniporter complex is uncharacterized
• Whether MICU2 has functions independent of the MCU complex has not been systematically tested